RentRedi Launches Alerts That Help Landlords Proactively Plan Renewals and Reduce Vacancies
PatientSync Selects Telnyx to Power AI-Driven Voice Experiences for Healthcare Enterprises
Geotab Survey: 87% of Professional Drivers are Ready to Embrace In-Cab AI Coaching
Pala Casino Spa Resort Successfully Upgrades to QCI’s Latest Enterprise Platform, AGI56
Talkdesk upgrades Copilot with agentic AI to help human agents tackle the toughest customer challenges
Interim Data Analysis anticipated in Early 2024 MINNEAPOLIS, July 24, 2023 (GLOBE NEWSWIRE) — Panbela…
Interim Data Analysis anticipated in Early 2024 MINNEAPOLIS, July 24, 2023 (GLOBE NEWSWIRE) — Panbela…
The Company to Host a Conference Call and Webcast on August 10, 2023, at 8:30…
The Company to Host a Conference Call and Webcast on August 10, 2023, at 8:30…
These new appointments bring extensive US and international experience in company leadership and development of…
These new appointments bring extensive US and international experience in company leadership and development of…
RiskScore is the first validated risk model that includes breast density, personal/family history and genetic…
RiskScore is the first validated risk model that includes breast density, personal/family history and genetic…
Keros Therapeutics announces U.S. Food and Drug Administration (“FDA”) has cleared its investigational new drug…
Keros Therapeutics announces U.S. Food and Drug Administration (“FDA”) has cleared its investigational new drug…
– Ms. Tomasello created and led global commercial and medical affairs functions at Kite Pharma…
– Ms. Tomasello created and led global commercial and medical affairs functions at Kite Pharma…
BEDFORD, Mass., July 24, 2023 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused…
BEDFORD, Mass., July 24, 2023 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused…
REDWOOD CITY, Calif., July 24, 2023 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a…
REDWOOD CITY, Calif., July 24, 2023 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a…
The study’s primary endpoint was reached and demonstrated statistically significant and clinically meaningful results These…
The study’s primary endpoint was reached and demonstrated statistically significant and clinically meaningful results These…
Venlo, The Netherlands, July 24, 2023 (GLOBE NEWSWIRE) — QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock…
Venlo, The Netherlands, July 24, 2023 (GLOBE NEWSWIRE) — QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock…